Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1991 1
1997 1
1999 1
2000 3
2001 5
2002 14
2003 36
2004 50
2005 40
2006 46
2007 41
2008 50
2009 42
2010 43
2011 42
2012 37
2013 33
2014 26
2015 25
2016 30
2017 20
2018 27
2019 8
2020 16
2021 15
2022 8
2023 9
2024 7
2025 8
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

620 results

Results by year

Filters applied: . Clear all
Page 1
N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties.
Cepaityte D, Leivaditis K, Varouktsi G, Roumeliotis A, Roumeliotis S, Liakopoulos V. Cepaityte D, et al. Int Urol Nephrol. 2023 Jun;55(6):1481-1492. doi: 10.1007/s11255-022-03455-3. Epub 2023 Jan 3. Int Urol Nephrol. 2023. PMID: 36593372 Free PMC article. Review.
Oxidative stress (OS) has been recognized as a pathophysiologic mechanism underlying the development and progression of chronic kidney disease (CKD). OS, which results from the disturbance of balance among pro-oxidants and antioxidants favoring the pro-oxidants, is present …
Oxidative stress (OS) has been recognized as a pathophysiologic mechanism underlying the development and progression of chronic kidney …
Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy.
Anderson SM, Park ZH, Patel RV. Anderson SM, et al. Ann Pharmacother. 2011 Jan;45(1):101-7. doi: 10.1345/aph.1P275. Epub 2011 Jan 4. Ann Pharmacother. 2011. PMID: 21205947 Review.
OBJECTIVE: To define the clinical role of intravenous N-acetylcysteine for prophylaxis of contrast-induced nephropathy (CIN). DATA SOURCES: Randomized controlled clinical trials were identified using a search of MEDLINE (1990-September 2010) with the s …
OBJECTIVE: To define the clinical role of intravenous N-acetylcysteine for prophylaxis of contrast-induced nephropat …
N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis.
Liu R, Nair D, Ix J, Moore DH, Bent S. Liu R, et al. J Gen Intern Med. 2005 Feb;20(2):193-200. doi: 10.1111/j.1525-1497.2005.30323.x. J Gen Intern Med. 2005. PMID: 15836554 Free PMC article.
We conducted a systematic review to determine whether administering N-acetylcysteine around the time of contrast administration reduces the risk of contrast-induced nephropathy. ...The relative risk of developing contrast-induced nephr …
We conducted a systematic review to determine whether administering N-acetylcysteine around the time of contrast admini …
High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy.
Trivedi H, Daram S, Szabo A, Bartorelli AL, Marenzi G. Trivedi H, et al. Am J Med. 2009 Sep;122(9):874.e9-15. doi: 10.1016/j.amjmed.2009.01.035. Am J Med. 2009. PMID: 19699385
BACKGROUND: Whether N-acetylcysteine is beneficial for the prevention of contrast-induced nephropathy is uncertain. ...CONCLUSION: Our results suggest that high-dose N-acetylcysteine decreases the incidence of contrast-induced n …
BACKGROUND: Whether N-acetylcysteine is beneficial for the prevention of contrast-induced nephropathy is uncerta …
N-acetylcysteine as Prophylaxis Against Contrast-Induced Nephropathy: A Meta-Analysis.
Rafique B, Arshad AR, Sabir S, Ijaz U, Rahman OU. Rafique B, et al. J Coll Physicians Surg Pak. 2026 Apr;36(4):508-519. doi: 10.29271/jcpsp.2026.04.508. J Coll Physicians Surg Pak. 2026. PMID: 42015439 Review.
This study aimed to determine the effect of N-acetylcysteine (NAC) in preventing contrast-induced nephropathy. A literature search was carried out in PubMed and Cochrane CENTRAL, and 49 studies were finally included. ...Neither oral nor IV NAC decrease …
This study aimed to determine the effect of N-acetylcysteine (NAC) in preventing contrast-induced nephropathy. A …
Role of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy: A Meta-analysis.
Loomba RS, Shah PH, Aggarwal S, Arora RR. Loomba RS, et al. Am J Ther. 2016 Jan-Feb;23(1):e172-83. doi: 10.1097/MJT.0b013e31829dbc1c. Am J Ther. 2016. PMID: 23982694
It is unclear whether N-acetylcysteine is useful in preventing contrast-induced nephropathy in patients undergoing coronary angiography. ...Separate analysis was conducted for all endpoints including only studies that used an N-acetylcysteine …
It is unclear whether N-acetylcysteine is useful in preventing contrast-induced nephropathy in patients undergoi …
N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.
Zagler A, Azadpour M, Mercado C, Hennekens CH. Zagler A, et al. Am Heart J. 2006 Jan;151(1):140-5. doi: 10.1016/j.ahj.2005.01.055. Am Heart J. 2006. PMID: 16368307
BACKGROUND: Contrast-induced nephropathy (CIN) following coronary angiography increases morbidity and mortality. ...Data extraction included patient characteristics, intravenous fluid regimen, type and dose of contrast media, dosing regimen, creatinine …
BACKGROUND: Contrast-induced nephropathy (CIN) following coronary angiography increases morbidity and mortality. ...Data extra …
N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
Shalansky SJ, Vu T, Pate GE, Levin A, Humphries KH, Webb JG. Shalansky SJ, et al. Pharmacotherapy. 2005 Aug;25(8):1095-103. doi: 10.1592/phco.2005.25.8.1095. Pharmacotherapy. 2005. PMID: 16207100 Review.
Use of oral N-acetylcysteine for preventing radiographic contrast material-induced nephropathy (RCIN) has become widespread, despite conflicting results from clinical trials and meta-analyses. ...If oral or intravenous N-acetylcysteine is …
Use of oral N-acetylcysteine for preventing radiographic contrast material-induced nephropathy (RCIN) has become …
[Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M, Möller A, Wassmer G, Brunkwall J. Gawenda M, et al. Zentralbl Chir. 2007 Jun;132(3):227-31. doi: 10.1055/s-2007-960756. Zentralbl Chir. 2007. PMID: 17610195 German.
PURPOSE: Clinical trials evaluating N-acetylcysteine (NAC) for the prevention of radiocontrast-induced nephropathy (RCN) have reported mixed results. ...Heterogenity was unexplained by subgroup analyses. SUMMARY AND CONCLUSIONS: N-acetylcysteine …
PURPOSE: Clinical trials evaluating N-acetylcysteine (NAC) for the prevention of radiocontrast-induced nephropathy (RCN …
Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.
Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA. Misra D, et al. Clin Cardiol. 2004 Nov;27(11):607-10. doi: 10.1002/clc.4960271106. Clin Cardiol. 2004. PMID: 15562929 Free PMC article.
METHODS: Trials were selected if they were prospective, randomized, controlled, had selected patients with impaired renal function, used low-osmolality, nonionic contrast media intra-arterially, administered a total of four doses of N-acetylcysteine in …
METHODS: Trials were selected if they were prospective, randomized, controlled, had selected patients with impaired renal function, used low …
620 results